It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
BACKGROUND: It is yet to be established which factors are responsible for differences among
patients with the same degree of coronary artery disease in terms of coronary collateral development
(CCD).
METHODS: Patients who had a greater than or equal to 95% stenosis in at least one epicardial
coronary artery were classified into two groups according to their glomerular filtration rate (GFR)
level. Afterwards, the degree of CCD was evaluated according to their plasma concentration of
asymmetric dimethylarginine (ADMA) and GFR levels.
RESULTS: Rentrop grade 2–3 was found more frequently in patients with GFR > 60 mL/min
than in patients with GFR < 60 mL/min (68.6% vs 41.4%, p = 0.032). Then we divided
patients into four groups according to their GFR levels and Rentrop grades; whereas we did
not find any significant difference for L-arginine or ADMA levels (respectively p = 0.629 and
p = 0.076), we did find a statistically significant difference between groups for L-arginine/
/ADMA ratio (p = 0.003) and this statistically significant difference was evident between
patients with GFR < 60 mL/min and Rentrop 0–1 and patients with GFR > 60 mL/min and
Rentrop 2–3 (1.23 vs 1.69, p < 0.001). Multivariate logistic regression analysis revealed that
L-arginine/ADMA ratio was the only variable which had a significant effect on CCD (OR = 1.016;
95% CI 1.001–1.031, Wald = 4.565; p = 0.033).
CONCLUSIONS: These results showed that CCD was poor in patients with GFR < 60 mL/min,
presumably because of the adverse effect of decreased L-arginine/ADMA ratio on endothelial
cells and angiogenesis. (Cardiol J 2012; 19, 1: 29–35)
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer